Follow
Stephen Senn
Stephen Senn
Consultant statistician, Edinburgh
Verified email at senns.uk - Homepage
Title
Cited by
Cited by
Year
Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations
S Greenland, SJ Senn, KJ Rothman, JB Carlin, C Poole, SN Goodman, ...
European journal of epidemiology 31 (4), 337-350, 2016
30462016
A 4-year trial of tiotropium in chronic obstructive pulmonary disease
DP Tashkin, B Celli, S Senn, D Burkhart, S Kesten, S Menjoge, ...
New England Journal of Medicine 359 (15), 1543-1554, 2008
30352008
The AB/BA design with normal data
S Senn
Cross-Over Trials in Clinical Research.” Chichester, West Sussex, England …, 1993
1675*1993
Cross-over trials in clinical research
S Senn
Wiley, 2002
16612002
Cross-over trials in clinical research
S SENN
Recherche 67, 02, 1992
1661*1992
Statistical issues in drug development
S Senn
Wiley-Interscience, 2007
9492007
Statistical Issues in Drug Development Wiley: Chichester
S Senn
949*1997
Testing for baseline balance in clinical trials
S Senn
Statistics in medicine 13 (17), 1715-1726, 1994
5191994
Guidelines for the content of statistical analysis plans in clinical trials
C Gamble, A Krishan, D Stocken, S Lewis, E Juszczak, C Doré, ...
Jama 318 (23), 2337-2343, 2017
4492017
Change from baseline and analysis of covariance revisited
S Senn
Statistics in medicine 25 (24), 4334-4344, 2006
3812006
Covariate imbalance and random allocation in clinical trials
SJ Senn
Statistics in medicine 8 (4), 467-475, 1989
3151989
Individual response to exercise training-a statistical perspective
A Hecksteden, J Kraushaar, F Scharhag-Rosenberger, D Theisen, ...
Journal of applied physiology 118 (12), 1450-1459, 2015
3012015
A systematic review of the antifungal effectiveness and tolerability of amphotericin B formulations
JP Barrett, KA Vardulaki, C Conlon, J Cooke, P Daza-Ramirez, ...
Clinical therapeutics 25 (5), 1295-1320, 2003
2342003
The relation between treatment benefit and underlying risk in meta-analysis
SJ Sharp, SG Thompson, DG Altman
Bmj 313 (7059), 735-738, 1996
2201996
Introduction to population pharmacokinetic/pharmacodynamic analysis with nonlinear mixed effects models
JS Owen, J Fiedler-Kelly
John Wiley & Sons, 2014
2022014
Surveillance of antimicrobial resistance—what, how and whither?
R Bax, R Bywater, G Cornaglia, H Goossens, P Hunter, V Isham, V Jarlier, ...
Clinical microbiology and infection 7 (6), 316-325, 2001
2012001
Some controversies in planning and analysing multi‐centre trials
S Senn
Statistics in Medicine 17 (15‐16), 1753-1765, 1998
1981998
Overstating the evidence–double counting in meta-analysis and related problems
S Senn
BMC medical research methodology 9 (1), 10, 2009
1972009
Mastering variation: variance components and personalised medicine
S Senn
Statistics in medicine 35 (7), 966-977, 2016
1882016
Seven myths of randomisation in clinical trials
S Senn
Statistics in medicine 32 (9), 1439-1450, 2013
1812013
The system can't perform the operation now. Try again later.
Articles 1–20